Table 2.
Brain areas and blood source | Sample size | Methods | lncRNA expression changes | lncRNA functions and roles in disease conditions | Citations | |
---|---|---|---|---|---|---|
Upregulation | Downregulation | |||||
ACC | 26 MDD suicide and 24 Controls | RNA-seq and qPCR validation | SNORD3C, LLNLF-65H9.1, RP1-269M15.3, AC006003.3, AC012507.3, AC013460.1, C9orf106, DYX1C1-CCPG1, RP1-63G5.5, RP11-1186N24.5, RP11-1391J7.1, RP11-143K11.5, RP11-273G15.2, RP11-434C1.1 ZNF833P | RP11-453F18_B.1, RP11-96D1.10, AC004019.18, CTC-487M23.5, CTD-2647L4.4, RP11-326G21.1, RP11-326I11.3, RP11-326I11.5 | The target genes Interferon regulatory factor 2 (IRF2, NM_002199), Lymphocyte antigen 6E (LY6E, NM_002346), and heme oxygenase (decycling) 1 (HMBOX1, NM_002133) (RP11-326I11.3, RP11-273G15.2, and CTD-2647L4.4) were successfully validated by qPCR | (79) |
dlPFC | 101 non-suicide, 50 non-violent suicide, 77 violent suicide (SCZ, MDD, and BD) | RNA-seq | LINC01268 | Violent suicide group and aggressiveness group had higher expression of LINC01268 | (28) | |
dlPFC | 77 non-suicide, 13 non-violent suicide, and 16 violent suicide (SCZ) | RNA-seq | LOC285758 expression was associated with violent suicide | (80) | ||
PBMC | 63 MDD non-suicidal ideation, 57 MDD suicidal ideation, and 63 Controls | qPCR | TCONS_00019174, ENST00000566208, NONHSAG045500, ENST00000517573, NONHSAT034045, NONHSAT142707 | (30) |
ACC, Anterior Cingulate Cortex; BD, Bipolar Disorder; dlPFC, dorsolateral prefrontal cortex; lncRNA, long non-coding RNA; MDD, Major Depressive Disorder; PBMC, Peripheral Blood Mononuclear Cell; SCZ, Schizophrenia.